Literature DB >> 35219848

Mammalian peroxidasin (PXDN): From physiology to pathology.

Guangjie Cheng1, Ruizheng Shi2.   

Abstract

Heme-containing peroxidases catalyze the oxidation of a variety of substrates by consuming hydrogen peroxide (H2O2), and play diversified roles in physiology and pathology including innate immunity, the synthesis of thyroid hormone and the extracellular matrix, as well as the pathogenesis of several inflammatory diseases. Peroxidasin (PXDN), also known as Vascular Peroxidase-1 (VPO1), is a newly identified peroxidase and expresses in multiple cells and tissues including cardiovascular system and the lung. Recent studies imply its roles in the innate immunity, cardiovascular physiology and diseases, and extracellular matrix formation. Studies on the role of PXDN in human diseases are entering a new and exciting stage, and this review provides the insights into this emerging field of PXDN.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Cell signaling; Enzyme; Gene mutation; Heme Peroxidase; Innate immunity; Pathology; Peroxidasin; Physiology

Mesh:

Substances:

Year:  2022        PMID: 35219848      PMCID: PMC8957557          DOI: 10.1016/j.freeradbiomed.2022.02.026

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  84 in total

Review 1.  Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway.

Authors:  Patrick Vallance; James Leiper
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-04-22       Impact factor: 8.311

2.  Bromine is an essential trace element for assembly of collagen IV scaffolds in tissue development and architecture.

Authors:  A Scott McCall; Christopher F Cummings; Gautam Bhave; Roberto Vanacore; Andrea Page-McCaw; Billy G Hudson
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

3.  Antibacterial Activity of the Lactoperoxidase System: A Review.

Authors:  Lisa M Wolfson; Susan S Sumner
Journal:  J Food Prot       Date:  1993-10       Impact factor: 2.077

Review 4.  Myeloperoxidase: friend and foe.

Authors:  Seymour J Klebanoff
Journal:  J Leukoc Biol       Date:  2005-02-02       Impact factor: 4.962

5.  Homozygous mutations in PXDN cause congenital cataract, corneal opacity, and developmental glaucoma.

Authors:  Kamron Khan; Adam Rudkin; David A Parry; Kathryn P Burdon; Martin McKibbin; Clare V Logan; Zakia I A Abdelhamed; James S Muecke; Narcis Fernandez-Fuentes; Kate J Laurie; Mike Shires; Rhys Fogarty; Ian M Carr; James A Poulter; Joanne E Morgan; Moin D Mohamed; Hussain Jafri; Yasmin Raashid; Ngy Meng; Horm Piseth; Carmel Toomes; Robert J Casson; Graham R Taylor; Michael Hammerton; Eamonn Sheridan; Colin A Johnson; Chris F Inglehearn; Jamie E Craig; Manir Ali
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

Review 6.  Remodelling the extracellular matrix in development and disease.

Authors:  Caroline Bonnans; Jonathan Chou; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12       Impact factor: 94.444

7.  The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.

Authors:  Constanze Bergt; Subramaniam Pennathur; Xiaoyun Fu; Jaeman Byun; Kevin O'Brien; Thomas O McDonald; Pragya Singh; G M Anantharamaiah; Alan Chait; John Brunzell; Randolph L Geary; John F Oram; Jay W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

8.  von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms.

Authors:  Jin-Li Zhang; Yi Huang; Li-Yan Qiu; Joachim Nickel; Walter Sebald
Journal:  J Biol Chem       Date:  2007-05-04       Impact factor: 5.157

9.  The role of vascular peroxidase 1 in ox-LDL-induced vascular smooth muscle cell calcification.

Authors:  Yixin Tang; Qian Xu; Haiyang Peng; Zhaoya Liu; Tianlun Yang; Zaixin Yu; Guangjie Cheng; Xiaohui Li; Guogang Zhang; Ruizheng Shi
Journal:  Atherosclerosis       Date:  2015-09-03       Impact factor: 5.162

10.  An examination of the regulatory mechanism of Pxdn mutation-induced eye disorders using microarray analysis.

Authors:  Yang Yang; Yiqiao Xing; Chaoqun Liang; Liya Hu; Fei Xu; Qi Mei
Journal:  Int J Mol Med       Date:  2016-04-20       Impact factor: 4.101

View more
  2 in total

Review 1.  Unexpected Role of MPO-Oxidized LDLs in Atherosclerosis: In between Inflammation and Its Resolution.

Authors:  Cecilia Tangeten; Karim Zouaoui Boudjeltia; Cedric Delporte; Pierre Van Antwerpen; Keziah Korpak
Journal:  Antioxidants (Basel)       Date:  2022-04-28

2.  A systematic pan-cancer analysis of PXDN as a potential target for clinical diagnosis and treatment.

Authors:  Xiaohu Zhou; Qiang Sun; Chang Xu; Zheng Zhou; Xiaoquan Chen; Xiuping Zhu; Zhaoshuai Huang; Weilin Wang; Yanjun Shi
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.